SNS Insider Black Friday Offer
Infusion Pump Software Market

Infusion Pump Software Market Size, Share & Segment by Type (Dose Error Reduction Software (DERS), Interoperability Software, Clinical Workflow Software), By Indication type (General Infusion, Pain and Anesthesia Management, Insulin Infusion, Chemotherapy, Enteral Infusion), By End User (Hospitals, Ambulatory Centers Settings, Home Healthcare Settings, Academic & Research Institutes), by Regions and Global Forecast 2022-2028

Report Id: SNS/HC/2033 | June 2022 | Region: Global | 125 Pages

Report Scope & Overview:

The Infusion Pump Software Market Size was valued at USD 859 million in 2021, and expected to reach USD 1434.5 million by 2028, and grow at a CAGR of 7.6% over the forecast period 2022-2028.

The infusion pump is a piece of equipment used in the process of giving patients fixed and controlled doses of fluids, including medications and nutrients. Insulin, antibiotics, chemotherapeutic treatments, and other drugs are among the medications and nutrients. The professionals who created the software interface and programmed the rate and duration of fluid flow often operate it. Utilizing the infusion pump software improves infusion management, lowers costs, and increases vehicle safety. It is commonly used in hospitals and ambulatory facilities.

Infusion Pump Software Market

They can be divided into two categories: 1) stationary purposes and 2) portable purposes.

Infusion pumps used in hospitals are stationary devices that cannot be transferred from one location to another. Travelers use portable infusion pumps because they are portable and can be used for home healthcare. Because patients who are taking medication need restricted and precise amounts, infusion pumps are used to provide painkillers, fluids, chemotherapeutic medications, and insulin.

These pumps are also employed in the management of diabetes and chronic illnesses. If we look at the statistics from the last few years, we can see that the prevalence rates of chronic diseases are rising and that technological advancements have contributed to the improvement of the healthcare industry. As a result, infusion pumps will be used more frequently.

MARKET DYNAMICS:

DRIVERS

  • Chronic Disease Incidence Is Rising, and the Geriatric Population Is Growing Quickly

  • Increasing Number of Surgical Operations

  • Increasing Demand for Infusion Pumps for Ambulatory and Home Care

  • Technological innovations

RESTRAINTS

  • Infusion Pumps are frequently subject to product recalls

OPPORTUNITIES

  • Emerging Markets Still Untapped

  • Specialty Infusion Systems are becoming more popular

CHALLENGES

  • Rising Medication Error Rates and Limited Wireless Access in Most Hospitals

IMPACT OF COVID-19

The global COVID-19 epidemic and the ensuing lockout have caused the healthcare market to continue to decline. Aside from affecting communities, COVID-19 had devastating effects on the major world economies, particularly the healthcare industry. Important parties are continuing to modify their tactics in response to the fast-shifting circumstances. The healthcare sector is expected to see severe long-term effects from COVID-19. Until the problem is resolved, significant players and nations would need to make important healthcare adjustments.

Remote diagnosis, treatment, and consultation were emphasized once more in COVID-19. Growth in Telehealth has been delayed over the last few years by legislative and behavioural obstacles. However, due to the fact that many healthcare providers are currently developing video conferencing and phone calls, this market's growth will multiply many times over the next two years. Patients with mild symptoms were also required to consult online as part of the social distancing policies. Additionally, it significantly lessens the strain on hospitals, who are already overburdened with COVID-19 patient counts. Medical IoT devices that reside at home with patients are currently employed to maximize outpatient therapy and reduce recurrent visits, and these devices can even be used in a crisis situation.

Extreme resource shortages were caused by the pandemic. Future market growth is anticipated to be accelerated by the creation of value-based pricing models and competitive pricing strategies. Due to these characteristics, COVID 19 is anticipated to have a substantial effect on the market for infusion pump software.

BY Type

The Dose Error Reduction Software (DERS), Clinical Workflow Software, Interoperability Software, and Other Software segments make up the infusion pump software industry. In the time of forecasting, the DERS segment is anticipated to rule the market. The medication library that comes with the infusion pump is used by DERS to carry out its functions. This programmed provides cutting-edge safety measures for infusion pumps, and as a result, it is predicted that its market will expand as more people use infusion pumps to provide medication incorrectly.

By Indication type

It is common practise to test drinking water quality, check for pesticides, and evaluate soil samples for contamination using infusion pump software. The general infusion, pain & anaesthetic management, insulin infusion, chemotherapy, enteral infusion, and others segments of the infusion pump software indications market are subdivided. During the projection period, it is anticipated that the general infusion category will hold the greatest share of the market. Due of infusion systems' ability to provide medications to patients safely and effectively for a variety of general health issues, a significant portion of this market can be attributed to them.

COMPETITIVE LANDSCAPE

Some of the major key players are as follows: Agilent Technologies, B Braun Melsungen AG, Fresenius Kabi, ICU Medical Inc., Roche Diagnostics, Micrel Medical Devices, Baxter International Inc., Medtronic Plc., Becton Dickinson and Company, Terumo Corporation.

MARKET SEGMENTS:

BY Type

  • Dose Error Reduction Software (DERS)

  • Interoperability Software

  • Clinical Workflow Software

By Indication type

  • General Infusion

  • Pain and Anesthesia Management

  • Insulin Infusion

  • Chemotherapy

  • Enteral Infusion

By End User

  • Hospitals

  • Ambulatory Centers Settings

  • Home Healthcare Settings

  • Academic & Research Institutes

Infusion Pump Software Market

REGIONAL ANALYSIS

One of the key markets is in North America. The rising revenue opportunities are in part due to the vibrant regulatory environments found in nations like the U.S. The U.S. FDA's supervision of the software development cycle and system-level testing has significantly accelerated innovation in the North American infusion pump software sector. In the global market for infusion pump software, Asia Pacific is starting to emerge as a potentially lucrative region. Product advances in the market during the past several years have been sparked by the rise in the deployment of smart infusion pumps in various clinical settings, particularly in acute care. Regarding patient safety when using these gadgets, healthcare professionals have grown more cautious. The development of the regional market is being aided by improvements made in the healthcare infrastructure of Asian countries.

REGIONAL COVERAGE

  • North America

    • USA

    • Canada

    • Mexico

  • Europe

    • Germany

    • UK

    • France

    • Italy

    • Spain

    • The Netherlands

    • Rest of Europe

  • Asia-Pacific

    • Japan

    • south Korea

    • China

    • India

    • Australia

    • Rest of Asia-Pacific

  • The Middle East & Africa

    • Israel

    • UAE

    • South Africa

    • Rest of Middle East & Africa

  • Latin America

    • Brazil

    • Argentina

    • Rest of Latin America

Infusion Pump Software Market Report Scope:
Report Attributes Details
Market Size in 2021 US$ 859 Million
Market Size by 2028 US$ 1434.5 Million
CAGR CAGR of 7.6% From 2022 to 2028
Base Year 2021
Forecast Period 2022-2028
Historical Data 2017-2020
Report Scope & Coverage Market Size, Segments Analysis, Competitive  Landscape, Regional Analysis, DROC & SWOT Analysis, Forecast Outlook
Key Segments • BY Type (Dose Error Reduction Software (DERS), Interoperability Software, Clinical Workflow Software)
• By Indication type (General Infusion, Pain and Anesthesia Management, Insulin Infusion, Chemotherapy, Enteral Infusion)
• By End User (Hospitals, Ambulatory Centers Settings, Home Healthcare Settings, Academic & Research Institutes)
Regional Analysis/Coverage North America (USA, Canada, Mexico), Europe
(Germany, UK, France, Italy, Spain, Netherlands,
Rest of Europe), Asia-Pacific (Japan, South Korea,
China, India, Australia, Rest of Asia-Pacific), The
Middle East & Africa (Israel, UAE, South Africa,
Rest of Middle East & Africa), Latin America (Brazil, Argentina, Rest of Latin America)
Company Profiles Agilent Technologies, B Braun Melsungen AG, Fresenius Kabi, ICU Medical Inc., Roche Diagnostics, Micrel Medical Devices, Baxter International Inc., Medtronic Plc., Becton Dickinson and Company, Terumo Corporation.
DRIVERS • Chronic Disease Incidence Is Rising, and the Geriatric Population Is Growing Quickly
• Increasing Number of Surgical Operations
• Increasing Demand for Infusion Pumps for Ambulatory and Home Care
RESTRAINTS • Infusion Pumps are frequently subject to product recalls


Frequently Asked Questions (FAQ) :

 In the time of forecasting, the DERS segment is anticipated to rule the market.

The Infusion Pump Software Market is dominated by North America.

Infusion Pumps are frequently subject to product recalls are the restraints of Ambulatory Surgical Centers Market

Ambulatory Surgical Centers Market is divided into three segments BY Type, By Indication Type, and By End User

 The infusion Pump Software market is expected to grow at a CAGR of 7.6% over the forecast period 2022-2028. 


Table of Contents

 

1. Introduction

1.1 Market Definition

1.2 Scope

1.3 Research Assumptions

 

2. Research Methodology

 

3. Market Dynamics

3.1 Drivers

3.2 Restraints

3.3 Opportunities

3.4 Challenges

 

4. Impact Analysis

4.1 COVID 19 Impact Analysis

4.2 Impact of Ukraine ware

 

5. Value Chain Analysis

 

6. Porter’s 5 forces model

 

7.  PEST Analysis

  

8. Infusion Pump Software Market Segmentation, BY Type

8.1 Dose Error Reduction Software (DERS)

8.2 Interoperability Software

8.3 Clinical Workflow Software

 

9. Infusion Pump Software Market Segmentation, By Indication type

9.1 General Infusion

9.2 Pain and Anesthesia Management

9.3 Insulin Infusion

9.4 Chemotherapy

9.5 Enteral Infusion

 

10. Infusion Pump Software Market Segmentation, By End User

10.1 Hospitals

10.2 Ambulatory Centers Settings

10.3 Home Healthcare Settings

10.4 Academic & Research Institutes

 

11. Regional Analysis

11.1 Introduction

11.2 North America

11.2.1 USA

11.2.2 Canada

11.2.3 Mexico

11.3 Europe

11.3.1 Germany

11.3.2 UK

11.3.3 France

11.3.4 Italy

11.3.5 Spain

11.3.6 The Netherlands

11.3.7 Rest of Europe

11.4 Asia-Pacific

11.4.1 Japan

11.4.2 South Korea

11.4.3 China

11.4.4 India

11.4.5 Australia

11.4.6 Rest of Asia-Pacific

11.5 The Middle East & Africa

11.5.1 Israel

11.5.2 UAE

11.5.3 South Africa

11.5.4 Rest

11.6 Latin America

11.6.1 Brazil

11.6.2 Argentina

11.6.3 Rest of Latin America

 

 

12.Company Profiles

12.1 Agilent Technologies

            12.1.1 Financial

12.1.2 Products/ Services Offered

12.1.3 SWOT Analysis

12.1.4 The SNS view

12.2 B Braun Melsungen AG

12.3 Fresenius Kabi

12.4 ICU Medical Inc.

12.5 Roche Diagnostics

12.6 Micrel Medical Devices

12.7 Baxter International Inc.

12.8 Medtronic Plc.

12.9 Becton Dickinson and Company

12.10 Terumo Corporation.

 

13.Competitive Landscape

13.1 Competitive Benchmark

13.2 Market Share analysis

13.3 Recent Developments

 

14.Conclusion

 

An accurate research report requires proper strategizing as well as implementation. There are multiple factors involved in the completion of the good and accurate research report and selecting the best methodology to complete the research is the toughest part. Since the research reports, we provide play a crucial role in any company’s decision-making process, therefore we at SNS Insider always believe that we should choose the best method which gives us results closer to reality. This allows us to reach at a stage wherein we can provide our clients best and accurate investment to output ratio.

Each report that we prepare takes a timeframe of 350-400 business hours for production. Starting from the selection of titles through a couple of in-depth brainstorming sessions to the final QC process before uploading our titles on our website we dedicate around 350 working hours. The titles are selected based on their current market cap and the foreseen CAGR and growth.

 

The 5 steps process:

Step 1: Secondary Research:

Secondary Research or Desk Research is as the name suggests is a research process wherein, we collect data through the readily available information. In this process we use various paid and unpaid databases which our team has access to and gather data through the same. This includes examining of listed companies’ annual reports, Journals, SEC filling etc. Apart from this our team has access to various associations across the globe across different industries. Lastly, we have exchange relationships with various university as well as individual libraries.

Secondary Research

Step 2: Primary Research

When we talk about primary research, it is a type of study in which the researchers collect relevant data samples directly, rather than relying on previously collected data.  This type of research is focused on gaining content specific facts that can be sued to solve specific problems. Since the collected data is fresh and first hand therefore it makes the study more accurate and genuine.

We at SNS Insider have divided Primary Research into 2 parts.

Part 1 wherein we interview the KOLs of major players as well as the upcoming ones across various geographic regions. This allows us to have their view over the market scenario and acts as an important tool to come closer to the accurate market numbers. As many as 45 paid and unpaid primary interviews are taken from both the demand and supply side of the industry to make sure we land at an accurate judgement and analysis of the market.

This step involves the triangulation of data wherein our team analyses the interview transcripts, online survey responses and observation of on filed participants. The below mentioned chart should give a better understanding of the part 1 of the primary interview.

Part 2: In this part of primary research the data collected via secondary research and the part 1 of the primary research is validated with the interviews from individual consultants and subject matter experts.

Consultants are those set of people who have at least 12 years of experience and expertise within the industry whereas Subject Matter Experts are those with at least 15 years of experience behind their back within the same space. The data with the help of two main processes i.e., FGDs (Focused Group Discussions) and IDs (Individual Discussions). This gives us a 3rd party nonbiased primary view of the market scenario making it a more dependable one while collation of the data pointers.

Step 3: Data Bank Validation

Once all the information is collected via primary and secondary sources, we run that information for data validation. At our intelligence centre our research heads track a lot of information related to the market which includes the quarterly reports, the daily stock prices, and other relevant information. Our data bank server gets updated every fortnight and that is how the information which we collected using our primary and secondary information is revalidated in real time.

Step 4: QA/QC Process

After all the data collection and validation our team does a final level of quality check and quality assurance to get rid of any unwanted or undesired mistakes. This might include but not limited to getting rid of the any typos, duplication of numbers or missing of any important information. The people involved in this process include technical content writers, research heads and graphics people. Once this process is completed the title gets uploaded on our platform for our clients to read it.

Step 5: Final QC/QA Process:

This is the last process and comes when the client has ordered the study. In this process a final QA/QC is done before the study is emailed to the client. Since we believe in giving our clients a good experience of our research studies, therefore, to make sure that we do not lack at our end in any way humanly possible we do a final round of quality check and then dispatch the study to the client.